Q3 2024 Lifeward Ltd Earnings Call Transcript
Key Points
- Lifeward Ltd (LFWD) reported a 39% increase in revenue over the prior year quarter, indicating strong business growth.
- The company successfully expanded its Medicare coverage, now reaching over 17,000 individuals with potential access to an additional 25,000.
- Lifeward's ReWalk Exoskeleton technology is gaining traction, with 20 more individuals regaining ambulation in the quarter.
- The company has streamlined operations, resulting in the lowest adjusted operating expenses in the past five quarters.
- Lifeward ended the quarter with $10.7 million in cash and no debt, providing a solid financial foundation for future growth.
- The AlterG business experienced slower-than-expected growth due to delays in capital expenditures and integration challenges.
- ReWalk sales were adversely affected by delays in Medicare case processing, impacting expected revenue.
- The gross margin percentage declined due to lower absorption of factory overhead costs and higher labor costs.
- The company revised its full-year revenue expectations downward to a range of $25 million to $26 million for 2024.
- The process for claims review and approval by Medicare is time-consuming, affecting the timing of payments and cash flow.
Good day, and welcome to the Lifeward's third-quarter 2024 earnings conference call. (Operator Instructions) Please note this event is being recorded. I would now like to turn the conference over to Mike Lawless, CFO. Please go ahead.
Thank you, Danielle. Good morning, and welcome to Lifeward's third-quarter 2024 earnings call. I'm Mike Lawless, Lifeward's Chief Financial Officer and with me on today's call is Larry Jasinski, our Chief Executive Officer; and Almog Adar, our Vice President of Finance.
Earlier this morning, Lifeward issued a press release detailing financial results for the three and nine months ended September 30, 2024, which, along with this call, discuss certain non-GAAP information. The press release, including relevant non-GAAP reconciliations and a webcast of this call can be accessed through the Investor Relations section of the Lifeward website at golifeward.com.
Before we get started, I'd like to remind everyone that any statements made on today's conference call that express a belief,
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
